Showing 1 - 7 results of 7 for search 'Marian Iwamoto', query time: 0.04s Refine Results
  1. 1
    Characterization of the absorption, metabolism, excretion, and mass balance of gefapixant in humans

    Characterization of the absorption, metabolism, excretion, and mass balance of gefapixant in humans by Jesse C. Nussbaum, Azher Hussain, Bennett Ma, K. Chris Min, Qing Chen, Charles Tomek, Marian Iwamoto, S. Aubrey Stoch

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Population pharmacokinetics of letermovir following oral and intravenous administration in healthy participants and allogeneic hematopoietic cell transplantation recipients

    Population pharmacokinetics of letermovir following oral and intravenous administration in healthy participants and allogeneic hematopoietic cell transplantation recipients by Marita Prohn, Anders Viberg, Da Zhang, Kevin Dykstra, Casey Davis, Sreeraj Macha, Philip Sabato, Dinesh deAlwis, Marian Iwamoto, Craig Fancourt, Carolyn R. Cho

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Assessment of pharmacokinetics, safety, and tolerability following twice‐daily administration of molnupiravir for 10 days in healthy participants

    Assessment of pharmacokinetics, safety, and tolerability following twice‐daily administration of molnupiravir for 10 days in healthy participants by Marian Iwamoto, Kelly E. Duncan, Prachi K. Wickremasingha, Tian Zhao, Maria V. Liberti, Lieselotte Lemoine, Tatjana Decaesteker, Sylvie Rottey, Brian M. Maas, Gillian Gillespie, S. Aubrey Stoch

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    P2 A single monotherapy dose of MK-8591, a novel NRTI, suppresses HIV for 10 days

    P2 A single monotherapy dose of MK-8591, a novel NRTI, suppresses HIV for 10 days by Martine Robberechts, Evan J. Friedman, Dirk Schürmann, Deanne Jackson Rudd, Inge De Lepeleire, Sabrina Fox-Bosetti, Sandra Zhang, Andreas Huser, Daria Hazuda, Marian Iwamoto, JayA Grobler

    Published 2016
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    Safety, tolerability, and pharmacokinetics of single‐ and multiple‐dose administration of islatravir (MK‐8591) in adults without HIV

    Safety, tolerability, and pharmacokinetics of single‐ and multiple‐dose administration of islatravir (MK‐8591) in adults without HIV by Randolph P. Matthews, Wendy Ankrom, Evan Friedman, Deanne Jackson Rudd, Yang Liu, Robin Mogg, Deborah Panebianco, Inge De Lepeleire, Magdalena Petkova, Jay A. Grobler, Selwyn Aubrey Stoch, Marian Iwamoto

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:
  6. 6
    O6 Single doses as low as 0.5 mg of the novel NRTTI MK-8591 suppress HIV for at least 7 days

    O6 Single doses as low as 0.5 mg of the novel NRTTI MK-8591 suppress HIV for at least 7 days by Inge De Lepeleire, Randolph P. Matthews, Dirk Schürmann, Deanne J. Rudd, Vanessa Levine, Sabrina Fox-Bosetti, Sandra Zhang, Martine Robberechts, Andreas Hüser, DariaJ Hazuda, JayA Grobler, Aubrey Stoch, Marian Iwamoto

    Published 2017
    Connect to this object online.
    Book
    Save to List
    Saved in:
  7. 7
    A phase I, randomized, placebo‐controlled study of molnupiravir in healthy Japanese to support special approval in Japan to treat COVID‐19

    A phase I, randomized, placebo‐controlled study of molnupiravir in healthy Japanese to support special approval in Japan to treat COVID‐19 by Keisuke Nakamura, Katsukuni Fujimoto, Chihiro Hasegawa, Ikuo Aoki, Hiroyuki Yoshitsugu, Hiroyuki Ugai, Naoyoshi Yatsuzuka, Yoshiyuki Tanaka, Kenichi Furihata, Brian M. Maas, Prachi K. Wickremasingha, Kelly E. Duncan, Marian Iwamoto, Selwyn A. Stoch, Naoto Uemura

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: